Marta E. Wosińska, PhD, is the Deputy Director, Policy, and Consulting Professor at the Duke-Margolis Center for Health Policy. Widely recognized as an expert on health policy, economics, and regulation, Dr. Wosińska leads the Center's Washington, DC office. In her role, she works with Duke-Margolis leadership on developing the Center’s strategy and then executes it with support of the roughly 30-person research team based in DC.
Dr. Wosińska’s experience spans both academia as well as the executive and legislative branches of the federal government. In 2019, Dr. Wosińska served as an economic advisor to the U.S. Senate Finance Committee, providing drug market analysis and expert guidance for the Committee’s bipartisan investigative and legislative work on drug pricing. Dr. Wosińska also served for over three years as Chief Healthcare Economist in the Office of Inspector General (OIG) at the US Department of Health and Human Services. Prior to OIG, Dr. Wosińska had a seven-year tenure at the US Food and Drug Administration (FDA) where she headed the Economics Staff at the Office of Strategic Programs in the Center for Drug Evaluation and Research and served as Senior Economic Advisor to FDA’s Deputy Commissioner for Medical Products and Tobacco, in both roles advising senior FDA leadership on a wide range of economic issues related to drugs and biologics.
Before entering public service, Dr. Wosińska was an Assistant Professor of Marketing at the Harvard Business School, where her academic research focused on prescription drug marketing. She also was a visiting Assistant Professor at the Columbia Business School, where she developed and taught Healthcare Marketing and Marketing of Pharmaceuticals and Medical Devices. Dr. Wosińska received her PhD in economics from University of California at Berkeley and a bachelor’s degree from Arizona State University.